SINT (SINTX Technologies) רווחיות מכירות לפי רווח גולמי

Gross margin growth reflects a recovery in profit dynamics, with the value stabilizing at 54.70. Sintx Technologies is collaborating with implant manufacturers to implement silicon nitride to combat infections. The development of ceramics relies on the expertise of biochemists and rigorous quality control. Management is currently adapting production capacities to meet commercial market demands while maintaining investor confidence.
פילוחי מדדים מקיפים ואנליטיקה עבור SINTX Technologies (SINT)

Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of the fundamental efficiency of value creation. An analysis of the net gross margin, with a current value of 54.70, reveals a critical gap between the costs of implementing orthopedic ceramics and actual revenues, confirming the working capital deficit of Sintx Technologies (SINT) and its reliance on equity issuances.